Regenexx Publishes World’s Largest Stem Cell Safety Paper!

stem cell safety research

We’ve published a lot of research and continue to add to those papers. As of this morning, if you add up the number of patients who have had their results published in the U.S. National Library of Medicine after some sort of bone marrow stem cell procedure for an orthopedic injury, the total is 8,549. With the publication of the world’s largest stem cell safety study by Regenexx in the Journal of International Orthopedics this week, 50% of those patients are ours.

What Did Regenexx Just Publish?

Stem cell safety is paramount in the minds of all physicians who use stem cells to treat orthopedic problems. To date, while we have several large safety studies that look at adverse events (side effects) of stem cells (two of those are our prior 2010 and 2011 studies), we have none that compare the safety of various techniques (i.e., same-day versus cultured cells). In addition, we have few large studies that look at all complications, with the biggest orthopedic same-day stem cell paper to date being focused only on whether there’s an increased risk of cancer (i.e., a kidney problem wouldn’t have shown up in this study).

Regenexx just published the world’s largest (2,372 patients) stem cell safety paper in any medical indication (not just orthopedics). This is the most in-depth analysis of safety available. In addition, it’s the longest follow-up period for a large group of patients where all complaints are reported. Finally, the data was collected at multiple treatment sites, and all complications that were considered significant were reviewed by a panel of five physicians and scientists who were not in any way affiliated with Regenexx (independent adjudication of SAEs).

Find a Regenexx Location Near You

77 clinic locations offering non-surgical Regenexx solutions for musculoskeletal pain.
77 clinic locations offering non-surgical Regenexx solutions for musculoskeletal pain.
Find a Location

What Do Other Doctors Have on Their Websites?

If you look around the Internet, it seems that every doctor who just took a weekend course on how to inject stem cells has research listed on his or her website. However, what you’ll quickly discover is that much of that research has little to do with the stem cell technique the doctor uses, and even less of it was published by that doctor on the technique being used. In essence, much of it is a bait and switch. Not at Regenexx; we’re the only group of clinics where you’ll find an extensive list of research publications, all of which pertain to the stem cell techniques we use and all of it published by us. So while other sites might provide a false sense of security, our research is published on what we actually do.

How Big a Footprint Does Regenexx Have in Orthopedic Stem Cell Research?

As of this morning, if we add up all of the patients who have had their results published after receiving bone marrow stem cells for orthopedic conditions, 50% of all published research listed in the U.S. National Library of Medicine has been published by Regenexx. That’s pretty impressive when you think about it, and it shows unparalleled dedication to moving this field forward and transparency.

Why don’t you see every stem cell clinic or group out there publishing? Research is expensive and time consuming, so it takes a large chunk out of the bottom line. It requires an expensive patient-tracking registry that employs many full-time people. It requires statistical experts, clinical research coordinators, and expert physicians to write the paper. After hundreds of man hours of work to shape a paper into something that can be submitted, peer review then adds many more hours of revisions and communication with editors.

The upshot! We’re proud to have this paper published. It’s a testament to our commitment to safety and our focus on moving the field forward. That’s why at Regenexx, the stem cell procedure you get is more advanced than anything else available!

Join us for a free Regenexx webinar.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Regenexx Updates in Your Inbox

Join our free newsletter.
Join the Regenexx Newsletter
Subscribe to Blog